Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Surya Prasad

Surya Prasad

BP Koirala Institue of Health Sciences, Nepal

Title: A randomized controlled trial of loading dose only versus standard dose magnesium sulfate seizure prophylaxis in severe pre-eclamptic women

Biography

Biography: Surya Prasad

Abstract

Magnesium sulfate is the drug of choice for prevention of seizures in the pre-eclamptic woman. There is no agreement in the published randomized trials regarding the optimal time to initiate magnesium sulfate, the dose to use (both loading and maintenance) as well as the duration of therapy. The objective of this study is to determine whether magnesium sulfate (MgSO4) prophylaxis is needed for up to 24 hours postpartum in all patients with severe pre-eclampsia for the prevention of seizure. The primary outcome measures were occurrence of seizure in each group. Secondary outcome measures were maternal and neonatal outcome.